Publication Search

Search for publications by

The burden of diabetes and hyperlipidemia in treated HIV infection and approaches for cardiometabolic care


Treatment of HIV infection with highly active antiretroviral therapy (HAART) confers survival and quality of life benefits. However, these significant benefits are at the cost of metabolic complications with associated increased risk of type 2 diabetes and cardiovascular disease. These chronic diseases add complexity to the standards of care in HIV infection and much remains unknown about the natural histories of diabetes and hyperlipidemia in this setting. This review examines recent research findings in diabetes and hyperlipidemia in HIV infection, juxtaposed on our prior understanding of these diseases. It also reviews the current evidence base and clinical guidelines for diabetes and lipid management and cardiometabolic prevention in HIV-infected HAART recipients.

Type Journal
ISBN 1548-3576 (Electronic) 1548-3568 (Linking)
Authors Samaras, K.;
Publisher Name Curr HIV/AIDS Rep
Published Date 2012-01-01 00:00:00
Published Volume 9
Published Issue 3
Published Pages 206-17
Status Published In-print
OpenAccess Link HIV Reports_.pdf